Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abatacept + methotrexate vs methotrexate alone in methotrexate-inadequate responder rheumatoid arthritis (Japan)
jRCT1080222075Phase 4
- Sponsor
- Bristol Myers Squibb
- Start
- May 2013
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in rheumatoid arthritis (RA) comparing Abatacept + methotrexate with Placebo + methotrexate (2 arms).
02
Drugs
abatacept
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on jRCT1080222075.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080222075.